Danish Prostate Cancer Consortium Study 1 (DPCC-1) protocol: Multicentre prospective validation of the urine-based three-microRNA biomarker model uCaP

INTRODUCTION: The primary objective of the Danish Prostate Cancer Consortium Study 1 (DPCC-1) is to provide validation for a novel urine-based microRNA biomarker, called uCaP, for a diagnosis of prostate cancer. METHODS AND ANALYSIS: Eligible participants are biopsy naïve men aged ≥18 years with pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Fredsøe, Jacob, Glud, Eske, Boesen, Lars, Løgager, Vibeke, Poulsen, Mads Hvid, Pedersen, Bodil Ginnerup, Borre, Michael, Sørensen, Karina Dalsgaard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632827/
https://www.ncbi.nlm.nih.gov/pubmed/37940151
http://dx.doi.org/10.1136/bmjopen-2023-077020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632827/
https://www.ncbi.nlm.nih.gov/pubmed/37940151
http://dx.doi.org/10.1136/bmjopen-2023-077020

Ejemplares similares